GIFLF:OTCMKTS
Grifols SA Class A
11,13 US$
0,00%
(0,00) 1 d
15 sep., 15:11:14 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för GIFLF …
Börsvärde
6,61 md
Genomsn. vol.
543,00
Volym
0,00
52v högst
12,90 US$
52v lägst
10,13 US$
Beta
0,90
Utestående aktier
426,13 mn
Antal anställda
25 tn
Börsvärde
6,61 md
Genomsn. vol.
543,00
Volym
0,00
52v högst
12,90 US$
52v lägst
10,13 US$
Beta
0,90
Utestående aktier
426,13 mn
Antal anställda
25 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
ad-hoc-news.de
·
för 1 timme sedan
Wall Street Zen downgrades Grifols stock from Buy to Hold
ad-hoc-news.de
·
för 21 timmar sedan
Grifols stock trades at EUR 10.03 with EUR 6.8 billion market value
AD HOC NEWS
·
för 3 dagar sedan
Grifols stock ends the week at EUR 9.88 within a EUR 9.73-9.97 range
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Om Grifols SA Class A